Stocks
Dicerna Pharmaceuticals (DRNA) ROE US GAAP (year values) |
|||||||||
| FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | LTM ? | CAGR 5 years ? | |||
| ROE, % | ? | -144.4% | -59.3% | -44.3% | -79.1% | -81.8% | -115.6% | ||
| Changes by years, y/y, % | -75pp | +85pp | +15pp | -35pp | -3pp | +3.5% | |||
Dicerna Pharmaceuticals. ROE, %
Dicerna Pharmaceuticals. ROE, changes, pp
Dicerna Pharmaceuticals (DRNA) ROE US GAAP (quarter values) |
||||||||
| FY2020Q3 | FY2020Q4 | FY2021Q1 | FY2021Q2 | FY2021Q3 | LTM ? | |||
| ROE, % | ? | -75.4% | -81.8% | -95.1% | -116.3% | -115.6% | -115.6% | |
| Changes by years, y/y, % | -1pp | -3pp | -29pp | -39pp | -40pp | |||
| Changes by quarters, q/q, % | +2pp | -6pp | -13pp | -21pp | +1pp | |||
